Tinea Pedis Treatment Market
Tinea Pedis Treatment Market Forecasts to 2030 - Global Analysis By Disease Indication (Vesicular Tinea Pedis, Plantar Tinea Pedis, Interdigital Tinea Pedis and Other Disease Indications), Route of Administration (Oral, Topical and Other Route of Administrations), Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies and Other Distribution Channels) and By Geography
According to Stratistics MRC, the Global Tinea Pedis Treatment Market is accounted for $1.4 billion in 2023 and is expected to reach $2.4 billion by 2030 growing at a CAGR of 7.4% during the forecast period. The Tinea Pedis Treatment Market refers to the pharmaceutical sector dedicated to addressing the fungal infection commonly known as athlete's foot. Tinea pedis, caused primarily by dermatophytes, affects the skin of the feet, particularly between the toes, leading to symptoms such as itching, redness, and flaking. This market provides pharmaceuticals, topical creams, ointments, and oral medications tailored to combat the fungal infection responsible for athlete's foot.
According to an article updated by NCBI in July 2022, it is estimated that about 10% of the total population is affected by dermatophyte infections of the toe clefts.
Market Dynamics:
Driver:
Growing geriatric population
Elderly individuals often have weakened immune systems, making them more susceptible to fungal infections like Tinea Pedis (athlete's foot). Age-related declines in mobility and flexibility can make proper foot hygiene and care more challenging, increasing the risk of contracting the infection. Moreover, elderly individuals commonly suffer from comorbidities such as diabetes and circulatory issues, which further elevate the likelihood of developing Tinea Pedis.
Restraint:
Resistance to antifungal drugs
As the prevalence of this fungal infection continues to rise, so does the reliance on antifungal medications. Prolonged and widespread use of these drugs has led to the development of resistance among fungal strains, rendering many conventional treatments ineffective. This resistance complicates patient management, prolongs treatment duration, increases healthcare costs, and heightens the risk of complications and recurrence. However, limited treatment options due to resistance diminishes patient satisfaction and quality of life, prompting a demand for alternative therapies.
Opportunity:
Advancements in treatment
With innovative therapies such as topical antifungal agents, oral medications, and advanced formulations, healthcare providers can address the infection more comprehensively, targeting its underlying causes with greater precision. These advancements have led to improved outcomes, quicker relief from symptoms, and reduced recurrence rates, thus enhancing patient satisfaction and compliance. Additionally, the development of combination therapies and novel delivery mechanisms has expanded treatment options, catering to diverse patient needs and preferences.
Threat:
Slow adoption of new therapies
While existing treatments such as antifungal creams and oral medications are available, their effectiveness can diminish due to emerging resistance and side effects. Consequently, there is a critical need for innovative therapies to address these shortcomings and improve patient outcomes. However, the adoption of such new therapies faces hurdles including rigorous regulatory processes, skepticism among healthcare providers, and limited awareness among patients. This slow uptake impedes the growth of the market by delaying the integration of advanced treatment options that could offer superior efficacy and safety profiles, ultimately prolonging the suffering of patients and limiting market expansion.
Covid-19 Impact:
With lockdowns and social distancing measures in place, individuals spent more time indoors, potentially increasing the prevalence of fungal infections like Tinea Pedis due to prolonged moisture exposure from wearing closed shoes and reduced ventilation. However, the disruption in healthcare services and prioritization of Covid-19 care led to delayed diagnoses and treatments for non-urgent conditions like fungal infections. This delay might have temporarily suppressed market growth as patients deferred seeking medical attention.
The Vesicular Tinea Pedis segment is expected to be the largest during the forecast period
Vesicular Tinea Pedis segment is expected to be the largest during the forecast period. Vesicular Tinea Pedis, a form of athlete's foot characterized by blisters, represents a considerable portion of the overall cases of the condition. Its prevalence has been steadily increasing, driven by factors such as poor foot hygiene, increased participation in sports, and the widespread use of communal facilities like gyms and swimming pools. Heightened awareness about foot health and the availability of various treatment options, including topical antifungal medications and oral therapies, have fueled market growth.
The Oral segment is expected to have the highest CAGR during the forecast period
Oral segment is expected to have the highest CAGR during the forecast period. Oral medications offer distinct advantages over topical treatments by providing systemic relief, targeting the infection from within the body. This approach proves particularly beneficial for severe or persistent cases where topical treatments might be insufficient. Additionally, oral medications offer convenience and ease of use compared to topical creams or ointments, making them a preferred choice for patients seeking efficient and comprehensive solutions.
Region with largest share:
The region of North America is anticipated to possess the largest share of the market throughout the projected period, owing to the extensive utilization of shared amenities such as swimming pools and gyms. Numerous treatments for tinea pedis, including over-the-counter and prescription drugs, have been developed and made available due to the region's thriving pharmaceutical sector. Furthermore, the region's expanding patient base, increasing medical facilities, and rising rates of fungal infections are all anticipated to fuel market expansion.
Region with highest CAGR:
Asia Pacific region is projected to witness profitable growth over the extrapolated period. As governments prioritize public health initiatives, they are increasingly focusing on regulating and standardizing the treatment of fungal infections like Tinea Pedis. These regulations often involve stringent requirements for product approval, manufacturing practices, and labeling, ensuring the safety and efficacy of treatments available to consumers. Moreover, government-funded healthcare programs and initiatives aimed at raising awareness about foot hygiene and fungal infections further stimulate market growth by driving demand for Tinea Pedis treatment products.
Key players in the market
Some of the key players in Tinea Pedis Treatment market include Novartis AG, Bayer AG, Valeant Pharmaceuticals International, Mylan NV, Perrigo Company Plc, Glenmark Pharmaceutical Ltd, GlaxoSmithKline plc, Teva Pharmaceuticals Industries Ltd, Camber Pharmaceuticals Inc, Sebela Pharmaceuticals Inc, Breckenridge Pharmaceutical, Inc, Blueberry Therapeutics Ltd and Aqua Pharmaceuticals LLC.
Key Developments:
In June 2023, A research team led by Kelvin Yeung from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has designed a new microneedle patch that provides an effective non-antibiotic approach for the treatment of skin infections including tinea pedis.
In March 2023, Candela, a Canadian medical device company, announced that the picosecond laser system was approved both by the FDA and by Health Canada on Wednesday. Previously, the laser system had been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkles.
In January 2023, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of the long-awaited SkinMedica® Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these three products work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face.
In June 2022, Kerasal launched a new Athlete's Foot product line, which features a unique formula with 5-in-1 benefits to help treat and heal most athletes' foot (tinea pedis), improve skin appearance and support a healthy footcare routine.
Disease Indications Covered:
• Vesicular Tinea Pedis
• Plantar Tinea Pedis
• Interdigital Tinea Pedis
• Other Disease Indications
Route of Administrations Covered:
• Oral
• Topical
• Other Route of Administrations
Distribution Channels Covered:
• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Tinea Pedis Treatment Market, By Disease Indication
5.1 Introduction
5.2 Vesicular Tinea Pedis
5.3 Plantar Tinea Pedis
5.4 Interdigital Tinea Pedis
5.5 Other Disease Indications
6 Global Tinea Pedis Treatment Market, By Route of Administration
6.1 Introduction
6.2 Oral
6.3 Topical
6.4 Other Route of Administrations
7 Global Tinea Pedis Treatment Market, By Distribution Channel
7.1 Introduction
7.2 Online Pharmacies
7.3 Retail Pharmacies
7.4 Hospital Pharmacies
7.5 Other Distribution Channels
8 Global Tinea Pedis Treatment Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Novartis AG
10.2 Bayer AG
10.3 Valeant Pharmaceuticals International
10.4 Mylan NV
10.5 Perrigo Company Plc
10.6 Glenmark Pharmaceutical Ltd
10.7 GlaxoSmithKline plc
10.8 Teva Pharmaceuticals Industries Ltd
10.9 Camber Pharmaceuticals Inc
10.10 Sebela Pharmaceuticals Inc
10.11 Breckenridge Pharmaceutical, Inc
10.12 Blueberry Therapeutics Ltd
10.13 Aqua Pharmaceuticals LLC
List of Tables
1 Global Tinea Pedis Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
3 Global Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
4 Global Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
5 Global Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
6 Global Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
7 Global Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
8 Global Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
9 Global Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
10 Global Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
11 Global Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
12 Global Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
13 Global Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
14 Global Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
15 Global Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
16 North America Tinea Pedis Treatment Market Outlook, By Country (2021-2030) ($MN)
17 North America Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
18 North America Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
19 North America Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
20 North America Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
21 North America Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
22 North America Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
23 North America Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
24 North America Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
25 North America Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
26 North America Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
27 North America Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
28 North America Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
29 North America Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
30 North America Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
31 Europe Tinea Pedis Treatment Market Outlook, By Country (2021-2030) ($MN)
32 Europe Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
33 Europe Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
34 Europe Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
35 Europe Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
36 Europe Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
37 Europe Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
38 Europe Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
39 Europe Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
40 Europe Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
41 Europe Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
42 Europe Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
43 Europe Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
44 Europe Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
45 Europe Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
46 Asia Pacific Tinea Pedis Treatment Market Outlook, By Country (2021-2030) ($MN)
47 Asia Pacific Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
48 Asia Pacific Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
49 Asia Pacific Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
50 Asia Pacific Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
51 Asia Pacific Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
52 Asia Pacific Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
53 Asia Pacific Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
54 Asia Pacific Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
55 Asia Pacific Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
56 Asia Pacific Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
57 Asia Pacific Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
58 Asia Pacific Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
59 Asia Pacific Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
60 Asia Pacific Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
61 South America Tinea Pedis Treatment Market Outlook, By Country (2021-2030) ($MN)
62 South America Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
63 South America Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
64 South America Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
65 South America Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
66 South America Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
67 South America Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
68 South America Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
69 South America Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
70 South America Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
71 South America Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
72 South America Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
73 South America Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
74 South America Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
75 South America Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
76 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Country (2021-2030) ($MN)
77 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Disease Indication (2021-2030) ($MN)
78 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Vesicular Tinea Pedis (2021-2030) ($MN)
79 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Plantar Tinea Pedis (2021-2030) ($MN)
80 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Interdigital Tinea Pedis (2021-2030) ($MN)
81 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Other Disease Indications (2021-2030) ($MN)
82 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
83 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Oral (2021-2030) ($MN)
84 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Topical (2021-2030) ($MN)
85 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
86 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
87 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
88 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
89 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
90 Middle East & Africa Tinea Pedis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
